We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+23.95%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.74B
AUM Growth
+$946M
Cap. Flow
+$105M
Cap. Flow %
1.56%
Top 10 Hldgs %
63.65%
Holding
393
New
188
Increased
79
Reduced
42
Closed
65

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$76M
2
NVO
Novo Nordisk
NVO
+$43.1M
3
FRPT icon
Freshpet
FRPT
+$41.5M
4
SBUX icon
Starbucks
SBUX
+$31.9M
5
BMY icon
Bristol-Myers Squibb
BMY
+$30.3M

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$79.6M
2
PTCT icon
PTC Therapeutics
PTCT
+$76M
3
GRFS
Grifois
GRFS
+$50.6M
4
STAA icon
STAAR Surgical
STAA
+$47.2M
5
TVTX icon
Travere Therapeutics
TVTX
+$40.5M

Sector Composition

Rank Sector Weight
1 Healthcare 31.9%
2 Technology 5.53%
3 Consumer Discretionary 5.27%
4 Communication Services 2.01%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIGL icon
51
Rigel Pharmaceuticals
RIGL
$736M
$20.5M 0.3%
724,000
-876,000
-55% -$26.2M
VYGR icon
52
Voyager Therapeutics
VYGR
$187M
$19.6M 0.29%
4,200,000
-600,000
-13% -$2.17M
S icon
53
SentinelOne
S
$7.21B
$19.6M 0.29%
1,111,200
-124,284
-10% -$2.23M
DT icon
54
Dynatrace
DT
$14.6B
$19.4M 0.29%
400,000
+176,012
+79% +$8.91M
MLYS icon
55
Mineralys Therapeutics
MLYS
$2.33B
$19.3M 0.29%
507,650
+329,650
+185% +$7.13M
VSTM icon
56
Verastem
VSTM
$509M
$18.5M 0.27%
2,096,000
-40,000
-2% -$298K
RH icon
57
RH
RH
$3.68B
$18.4M 0.27%
90,685
+68,393
+307% +$14.9M
ISRG icon
58
Intuitive Surgical
ISRG
$132B
$18.3M 0.27%
41,000
+18,005
+78% +$8.64M
ANGO icon
59
AngioDynamics
ANGO
$617M
$18.3M 0.27%
1,636,000
+108,185
+7% +$1.04M
PATH icon
60
UiPath
PATH
$7.18B
$18M 0.27%
1,344,284
+652,284
+94% +$7.71M
PRTA icon
61
Prothena Corp
PRTA
$441M
$17.8M 0.26%
1,824,000
-412,000
-18% -$3.17M
ELF icon
62
e.l.f. Beauty
ELF
$5.15B
$17.6M 0.26%
132,965
+86,510
+186% +$10.7M
RBLX icon
63
Roblox
RBLX
$25.9B
$17.4M 0.26%
+125,921
New +$15.6M
GTLB icon
64
GitLab
GTLB
$6.13B
$17M 0.25%
376,858
+53,299
+16% +$2.44M
ROST icon
65
Ross Stores
ROST
$81.1B
$16.9M 0.25%
111,138
+30,120
+37% +$4.3M
TSM icon
66
TSMC
TSM
$2.17T
$15.8M 0.23%
56,700
+15,700
+38% +$3.84M
VRTX icon
67
Vertex Pharmaceuticals
VRTX
$123B
$15.8M 0.23%
+40,239
New +$16.8M
FIVN icon
68
CALL
FIVE9
FIVN
$2.26B
$15.7M 0.23%
650,000
-770,000
-54% -$20.4M
CTOR
69
Citius Oncology
CTOR
$69.4M
$15.6M 0.23%
+7,675,911
New +$16.6M
VERA icon
70
Vera Therapeutics
VERA
$2.17B
$15.6M 0.23%
536,000
+400,000
+294% +$9.25M
NKTR icon
71
Nektar Therapeutics
NKTR
$2.46B
$15.2M 0.23%
268,000
+144,000
+116% +$4.77M
WYNN icon
72
Wynn Resorts
WYNN
$10.6B
$15M 0.22%
116,944
+72,087
+161% +$8.32M
WDAY icon
73
Workday
WDAY
$42B
$14.7M 0.22%
60,892
-3,124
-5% -$722K
NVDA icon
74
NVIDIA
NVDA
$5.35T
$14.4M 0.21%
76,944
+14,944
+24% +$2.6M
APP icon
75
Applovin
APP
$141B
$14M 0.21%
19,520
+4,450
+30% +$2.05M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Armistice Capital held 393 positions worth $6.74B, up 16% from $5.8B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Armistice Capital's Q3 2025 filing shows 188 new, 79 increased, 42 reduced and 65 closed positions. Its largest new stake was Novo Nordisk: 736,000 shares worth $40.8M. The largest sale was Supernus Pharmaceuticals, an estimated $79.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Armistice Capital's largest Q3 2025 buy was Novo Nordisk: 736,000 shares worth $40.8M.
  • Armistice Capital added most to Dentsply Sirona in Q3 2025, an estimated $76M increase.
  • Armistice Capital's biggest Q3 2025 reduction was Supernus Pharmaceuticals, cutting an estimated $79.6M.
  • Armistice Capital fully exited STAAR Surgical in Q3 2025, selling an estimated $47.2M.
  • Armistice Capital's ten largest holdings make up 64% of its $6.74B portfolio in Q3 2025.
  • Armistice Capital opened 188 new positions and closed 65 in Q3 2025.
  • Armistice Capital's portfolio value rose 16% quarter-over-quarter to $6.74B.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.